Publication | Closed Access

Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial

Squamous Cell CarcinomaMedicinePharmacologyDocetaxel Versus CisplatinPathologyBronchial NeoplasmAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology